Advertisement
Screener

SPECTRAL AI, INC. (MDAI) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings

SPECTRAL AI, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings

SPECTRAL AI, INC. (MDAI) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of -$12.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-06.

Financial Statements › Income Statement › Other Income

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2024-11-06

  • SPECTRAL AI, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2024-09-30 was -$12.00K.
  • SPECTRAL AI, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2024-06-30 was -$11.00K, a 113.58% decline year-over-year.
  • SPECTRAL AI, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2024-03-31 was -$20.00K.
  • SPECTRAL AI, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2024-03-30 was -$20.00K.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month
2024-09-30-$12.00K
10-Q · filed 2024-11-06
-$23.00K
derived: sum of 2 quarters · filed 2024-11-06
-$43.00K
derived: sum of 3 quarters · filed 2024-11-06
2024-06-30-$11.00K
10-Q · filed 2024-11-06
-$31.00K
derived: sum of 2 quarters · filed 2024-11-06
2024-03-31-$20.00K
10-Q · filed 2024-08-12
2024-03-30-$20.00K
10-Q · filed 2024-11-06
2023-09-30-$141.00K
10-Q · filed 2024-11-06
-$60.00K
derived: sum of 2 quarters · filed 2024-11-06
-$76.00K
derived: sum of 3 quarters · filed 2024-11-06
2023-06-30$81.00K
10-Q · filed 2024-11-06
$65.00K
derived: sum of 2 quarters · filed 2024-11-06
2023-03-31-$16.00K
10-Q · filed 2024-11-06
2022-09-30-$22.00K
10-Q · filed 2023-11-14
$16.00K
derived: sum of 2 quarters · filed 2023-11-14
-$50.00K
derived: sum of 3 quarters · filed 2023-11-14
2022-06-30$38.00K
10-Q · filed 2023-11-14
-$28.00K
derived: sum of 2 quarters · filed 2023-11-14
2022-03-31-$66.00K
10-Q · filed 2023-11-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
TELA Bio, Inc. (TELA)United States$0.057B-0.82
NEPHROS INC (NEPH)United States$0.046B23.02
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
DarioHealth Corp. (DRIO)$0.066B-1.39
CVRx, Inc. (CVRX)United States$0.067B-2.62
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18